Within cancer research circles, there has been quite a bit of press about immunotherapy and the Vice President’s Cancer Moonshot program. Ultimately, this program is looking to streamline how cancer research is done in order to increase the speed of discovery that will produce 10 years of progress within five years.
Many universities and federal agencies have research integrity policies that focus on misconduct and improper behaviors, whereas few provide principles of research integrity explaining model behaviors to which researchers can aspire and why such behaviors are important to the research process. By focusing on the negative aspects, research integrity becomes a punitive action associated with compliance and policing. Putting a positive spin on research integrity is an opportunity for providing professional development to researchers.
After many years of advocating for a “master protocol” for clinical trials, the Friends of Cancer Research has finally gained the support from pharmaceutical companies and the Food and Drug Administration. This is (potentially) good news.